Personalis Reports Second Quarter Results and Recent Highlights
Personalis reported Q2 revenue of $22.4 million, up 30% year-over-year, driven primarily by a 442% surge in clinical revenue to $2.6 million. Clinical test volume jumped 199% YoY to 10,384 tests, bolstered by new Medicare coverage approvals for NeXT Personal in immunotherapy monitoring and neoadjuvant breast cancer monitoring.
Key figures
- Revenue
- 22400000
- Guidance
- Suspended due to pending merger with Tempus AI
- Revenue Yoy
- 30%
- Cash position
- 212700000
- Clinical tests
- 10384
- Clinical revenue
- 2600000
- Clinical tests yoy
- 199%
- Clinical revenue yoy
- 442%
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.